Patient Experiences with Liposomal Daunorubicin and Cytarabine (CPX-351) Versus Conventional Induction Regimens: An Analysis of Patient-Reported Outcomes Data from a Prospective Trial
Authors:
Open Access
- 5 November 2020
- journal article
- abstracts
- Published by American Society of Hematology in Blood
- Vol. 136 (Supplement) , 29-30